Bank of Montreal’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.41M Buy
9,700
+7,500
+341% +$2.67M ﹤0.01% 1466
2025
Q4
$720K Buy
+2,200
New +$698K ﹤0.01% 2145
2024
Q1
Sell
-19,500
Closed -$5.63M 3856
2023
Q4
$5.63M Buy
19,500
+6,900
+55% +$1.88M ﹤0.01% 1231
2023
Q3
$3.3M Buy
+12,600
New +$3.14M ﹤0.01% 1463
2022
Q2
Sell
-29,000
Closed -$7.4M 4061
2022
Q1
$7.4M Buy
+29,000
New +$6.66M ﹤0.01% 1293

Other funds holding AMGN

Bank of Montreal's AMGN Position: Q1 2026 in Review

Bank of Montreal reduced its Amgen (AMGN) stake by 11% in Q1 2026, selling an estimated $43.7M and leaving 961,165 shares worth $338M. The position accounts for 0.13% of the portfolio, ranked #143.

Bank of Montreal first reported a position in AMGN in Q2 2013 and has held it in 52 quarters since. The position peaked at $602M in Q2 2021. 3,132 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Bank of Montreal held 961,165 shares of Amgen worth $338M as of Q1 2026.
  • Bank of Montreal sold 122,655 Amgen shares in Q1 2026, an estimated $43.7M.
  • Amgen made up 0.13% of Bank of Montreal's portfolio in Q1 2026, its #143 holding.
  • Bank of Montreal first reported a position in Amgen in Q2 2013 and has held it in 52 quarters since.
  • Bank of Montreal's Amgen position peaked at $602M in Q2 2021.
  • 3,132 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Bank of Montreal's 13F filing for Q1 2026, filed 13 May 2026.